You are here: Home » Current Affairs » Coronavirus » News
Business Standard

Adverse event cases after Covid-19 vaccination just one in 2,000: Govt

Dispelling rumours, NITI Aayog member (Health) V K Paul said the vaccination will not impact fertility in any manner

Coronavirus Tests | Coronavirus Vaccine

Press Trust of India  |  New Delhi 

vaccine, pharma, coronavirus, medicine, drugs, medical research, covid, lab
Representational image

Just one out of 2,000 beneficiaries report minor effects post vaccination against COVID-19, the Centre on Tuesday said, noting that the rate of adverse event following immunisation has been recorded at 0.05 per cent.

Dispelling rumours, NITI Aayog member (Health) V K Paul said the vaccination will not impact fertility in any manner.

"The AEFI is 0.05 per cent, it is 1 in 2000 there is slight pain or fever. Spreading rumours like it will impact fertility are not true. The vaccines are eminently safe. I will appeal anganwadi workers and nurses to get vaccinated," he said.

ICMR Director General Balram Bhargava further added that those taking aspirin and blood thinner can also be given these vaccines.

"There is no contraindication," he said.

Paul further said 24 countries have been sent vaccinations from India.

He urged people to maintain vigil and keep following COVID appropriate behaviour.

"70 per cent Indian population is still vulnerable. Vigil to contain this virus must continue. We still don't fully understand the virus so we have to be serious about vaccination and COVID-19's appropriate behaviour," he said.

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Tue, February 16 2021. 20:59 IST